&nbsp;

OBSP-15-1-21.html

Jan 2021

Document

obsp-22-1-21.xml

Jan 2021

Document

OBSP-22-1-21.html

Jan 2021

Guidelines and Advice

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) Joint Guideline Update

Status: Current
ID: 7-A-2018-3

Feb 2021

Document

obsp-18-2-21.xml

Feb 2021

Document

OBSP-18-2-21.html

Feb 2021

Regimen

OLAP

Cancer Type:

Genitourinary,

Prostate

Intent: Palliative

Funding:

Exceptional Access Program

olaparib - For the treatment of metastatic castration resistant prostate cancer (mCRPC), based on criteria

, Collapse Show fewer tags

Drugs Used:

olaparib

... Show more tags

Quick Link(s):

Regimen Monograph

Dec 2024

Regimen

TRAS

Cancer Type:

Gynecologic,

Endometrial

Intent: Palliative, Curative

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Advanced or Recurrent Endometrial Cancer

, Collapse Show fewer tags

Drugs Used:

trastuzumab

... Show more tags

Quick Link(s):

Regimen Monograph

Oct 2024

Document

obsp-17-3-21.xml

Mar 2021

Document